Design Therapeutics (DSGN) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.31
-0.27
-0.24
-0.2

Details

Expected EPS
-0.243333
Actual EPS
-0.23
Surprise EPS
0.01
Surprise Percent
+5.48%

Description

Design Therapeutics (DSGN) has reported earnings of -0.23 per share for Q4 2024.

0 Comments

Share your thoughts